Catalyst News and Research

RSS

Midnolin protein plays key role in breaking down short-lived nuclear proteins

Short-lived proteins control gene expression in cells to carry out a number of vital tasks, from helping the brain form connections to helping the body mount an immune defense.

24 Aug 2023

Project NextGen awards over $1.4 billion to develop the future of COVID-19 vaccines and therapeutics

Funding includes $1 billion for vaccine clinical trials, $326 million for a new monoclonal antibody, and $100 million to explore novel vaccine and therapeutic technologies.

23 Aug 2023

Structural explanations for inequality can reduce bias in children

Children's views of inequality may be influenced by how its causes are explained to them, finds a new study by a team of psychology researchers.

21 Aug 2023

Virginia Tech engages in three collaborative bioscience projects to address unmet health care needs

With funding from Virginia Catalyst, also known as the Virginia Biosciences Health Research Corp., Virginia Tech is engaged in three collaborative bioscience projects to address unmet health care needs in Virginia, according to Michael Friedlander, vice president for health sciences and technology at Virginia Tech.

8 Aug 2023

Unexpected link between pure mathematics and genetics discovered

An interdisciplinary team of mathematicians, engineers, physicists, and medical scientists have uncovered an unexpected link between pure mathematics and genetics, that reveals key insights into the structure of neutral mutations and the evolution of organisms.

8 Aug 2023

NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer

The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular mechanisms that drive the most common form of breast cancer.

7 Aug 2023

TU Graz researchers gain new insights into a light-activated protein switch

Researchers at TU Graz have gained new insights into the functioning of a protein found in bacteria, whose enzymatic activity is activated by blue light.

3 Aug 2023

COST catalyzes collaborative research in transcriptomics for cardiovascular disease

The Action has not only catalyzed research in this area by bringing together almost 300 participants from across Europe and beyond, but it also catalyzed the careers of younger researchers and launched a Horizon 2020 project: COVIRNA.

2 Aug 2023

UCLA study finds new way to protect livers during transplantation

UCLA-led research describes the role that a protein called CEACAM1 plays in protecting the liver from injury during the transplantation process, potentially improving transplant outcomes.

2 Aug 2023

Scientists develop breakthrough technology for detecting protein modifications

A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.

1 Aug 2023

New device can detect COVID-19 in less than a minute

Benjamin Sumlin, PhD, a senior scientist at Washington University in St. Louis, blows into a device designed by researchers at the university. The device — a breath test that uses a biosensor — could become a tool for use in doctors' offices to quickly diagnose people infected with the virus that causes COVID-19.

1 Aug 2023

New way to create unnatural amino acids identified

Every protein in your body is made up of the same 20 building blocks called amino acids. But just because nature is stuck with a limited toolkit doesn't mean humans can't expand it.

1 Aug 2023

Routine brain scans could help identify physical causes of psychosis

Routine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, according to a new study.

31 Jul 2023

Study offers new insight into how antimicrobial resistance emerges in patients with bacterial infections

A research study led by the University of Oxford provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections.

31 Jul 2023

Third dose COVID-19 booster vaccines offer lasting protection, trial shows

Third dose COVID-19 booster vaccines offer lasting protection after several months, according to the latest results of a nationwide trial.

25 Jul 2023

Researchers convert β-Pinene into renewable feedstock for sustainable paracetamol and ibuprofen

Researchers have developed scalable processes to convert β-pinene into 4-IPEC, a feedstock for synthesizing sustainable versions of paracetamol and ibuprofen.

19 Jul 2023

COVID-19 school closures hit poorer districts of Barcelona hardest, study finds

The COVID-19 pandemic hit the educational systems. It is estimated that approximately 1.6 billion children worldwide were affected by school closures, which had a major impact on their learning.

17 Jul 2023

Study provides a transformational new insight into emergence of antimicrobial resistance

A research study led by the University of Oxford provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections.

12 Jul 2023

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

On July 6, 2023, the U.S. Food and Drug Administration granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer's disease.

12 Jul 2023

High tumor monocyte content linked to better outcomes for esophageal cancer patients

A Ludwig Cancer Research study has discovered that the presence of relatively high numbers of immune cells known as monocytes in tumors is linked to better outcomes in esophageal cancer patients treated with a combination of chemotherapy and immunotherapy, or immunochemotherapy.

10 Jul 2023

Catalyst News and Research

Midnolin protein plays key role in breaking down short-lived nuclear proteins

Project NextGen awards over $1.4 billion to develop the future of COVID-19 vaccines and therapeutics

Structural explanations for inequality can reduce bias in children

Virginia Tech engages in three collaborative bioscience projects to address unmet health care needs

Unexpected link between pure mathematics and genetics discovered

NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer

TU Graz researchers gain new insights into a light-activated protein switch

COST catalyzes collaborative research in transcriptomics for cardiovascular disease

UCLA study finds new way to protect livers during transplantation

Scientists develop breakthrough technology for detecting protein modifications

New device can detect COVID-19 in less than a minute

New way to create unnatural amino acids identified

Routine brain scans could help identify physical causes of psychosis

Study offers new insight into how antimicrobial resistance emerges in patients with bacterial infections

Third dose COVID-19 booster vaccines offer lasting protection, trial shows

Researchers convert β-Pinene into renewable feedstock for sustainable paracetamol and ibuprofen

COVID-19 school closures hit poorer districts of Barcelona hardest, study finds

Study provides a transformational new insight into emergence of antimicrobial resistance

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

High tumor monocyte content linked to better outcomes for esophageal cancer patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News